Trial Profile
EEG spectral power density profiles during NREM sleep for gaboxadol in patients with primary insomnia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2012
Price :
$35
*
At a glance
- Drugs Gaboxadol - Ovid Therapeuticsgaboxadol (Primary)
- Indications Insomnia
- Focus Pharmacodynamics
- Sponsors Lundbeck A/S
- 11 Sep 2012 New trial record